google adsense check
Home INTERNATIONAL Abbott India, Pfizer, L&T Infotech: 11 stocks that might enter F&O segment

Abbott India, Pfizer, L&T Infotech: 11 stocks that might enter F&O segment

&#13
&#13
Pharma businesses such as Abbott India, Pfizer, and Ipca Lab are between the eleven businesses that, in accordance to ICICI Securities, are probably to be included in the futures & options (F&O) phase.&#13
&#13
In the past F&O inclusion, NSE had declared the introduction of SBI Life Insurance in April 2020. Prior to that, in February 2020, 3 new shares have been added to the F&O segment following a gap of nearly two yrs, the report adds.&#13
&#13
&#13
&#13
&#13
&#13
The eligibility of stock inclusion in the derivatives / F&O phase is based mostly on the criteria laid down by market regulator Securities and Trade Board of India (Sebi) by way of several circulars issued from time to time.&#13
&#13
Accordingly, the inventory shall be picked out from among the top 500 stocks in conditions of typical daily market capitalisation and common day by day traded value in the former 6 months on a rolling basis and also the stock’s median quarter-sigma order size in excess of the past six months shall not be significantly less than Rs 25 lakh. Browse More&#13
&#13
Other shares that qualify for the F&O inclusion are Aarti Industries, Adani Gasoline, ICICI General Insurance, PI Industries, and Trent, L&T Infotech, HDFC AMC, and Deepak Nitrite.&#13
&#13
For the quarter finished March 2020, MNC pharma company Abbott India claimed a 1.96 for every cent decline in net profit at Rs 110.97 crore, generally on account of rise in expenses. Revenue from operations stood at Rs 961.20 crore for the quarter underneath consideration as in opposition to Rs 906.31 crore for the same period of time 12 months in the past.&#13
&#13
Pfizer, way too, experienced claimed 5.90 for every cent decline in its net profit at Rs 103.01 crore for the quarter ended March 2020 as from Rs 109.47 crore for the duration of the former quarter finished March 2019.&#13
&#13
Product sales for the quarter beneath assessment declined 6.28 per cent to Rs 502.01 crore.&#13
&#13
The domestic pharma organization, Ipca Lab, on the other hand, posted a decrease of 12.72 per cent in its net profit for the quarter under evaluate at Rs 86.01 crore. Sales for the firm rose 22 for every cent to Rs 1073.76 crore yr-on-year.&#13

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

SBI Card Share Price: Trending stocks: SBI Card shares trade flat in early session

NEW DELHI: Shares of SBI Playing cards and Payment Expert services Ltd. traded .15 per cent up in Wednesday's trade at 10:25AM (IST). Around...

UPDATE 1-Dying toll from NLC India boiler blast rises to 13

(Adds information on investigation, background)By Sudarshan Varadhan and Derek FrancisCHENNAI/BENGALURU, July 8 (Reuters) - NLC India reported on Wednesday the loss of life...

porinju: Porinju Veliyath’s Equity Intelligence cuts stake in this paint firm

Equity Intelligence India, the portfolio administration company owned by Kochi-primarily based trader Porinju Veliyath, minimize stake in Shalimar Paints to 1.66 per cent all...

Recent Comments